European Medicines Agency

(redirected from Committee on Orphan Medicinal Products)
Also found in: Wikipedia.

European Medicines Agency

The drug regulatory agency for the European Union, which is located in London. The EMA is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the EU.
References in periodicals archive ?
We value the positive recognition from the EMEA's Committee on Orphan Medicinal Products of the potential for Cethrin to provided significant benefit to patients who experience a serious spinal cord injury.
In a related European regulatory action, last month ADVEXIN was recommended for Orphan Drug Status for the treatment of LFS by the EMEA's Committee on Orphan Medicinal Products.

Full browser ?